Kitching A R, Tipping P G, Timoshanko J R, Holdsworth S R
Center for Inflammatory Diseases, Monash University Department of Medicine, Monash Medical Center, Clayton, Victoria, Australia.
Kidney Int. 2000 Feb;57(2):518-25. doi: 10.1046/j.1523-1755.2000.00872.x.
Interleukin (IL)-10 plays a pivotal role in regulating the Th1/Th2 predominance of immune responses. Exogenously administered IL-10 suppresses nephritogenic Th1 responses, inhibits macrophage function, and attenuates crescentic glomerulonephritis (GN). To determine the role of endogenous IL-10, the development of the nephritogenic immune response and crescentic GN was compared in IL-10-deficient (IL-10-/-) and normal (IL-10+/+) C57BL/6 mice.
GN was initiated in sensitized mice by the intravenous administration of sheep antimouse glomerular basement membrane globulin. Renal injury was evaluated 21 days later.
Following the administration of anti-glomerular basement membrane globulin, normal (IL-10+/+) C57BL/6 mice developed proliferative GN with occasional crescents, glomerular CD4+ T-cell and macrophage accumulation, and fibrin deposition. Using an identical induction protocol, IL-10-/-mice developed more severe GN. Crescent formation (IL-10-/-, 23 +/- 2% of glomeruli; IL-10+/+, 5 +/- 2%), glomerular CD4+ T cells [IL-10-/-, 1. 0 +/- 0.2 cells per glomerular cross-section (c/gcs); IL-10 +/+, 0.3 +/- 0.05 c/gcs], glomerular macrophages (IL-10-/-, 4.8 +/- 0.3 c/gcs; IL-10 +/+, 1.7 +/- 0.2 c/gcs), fibrin deposition [fibrin score (range 0 to 3+); IL-10-/-, 1.10 +/- 0.04; IL-10+/+, 0.6 +/- 0. 07], and serum creatinine (IL-10-/-, 30 +/- 2 micromol/L; IL-10 +/+, 23 +/- 1 micromol/L) were all significantly increased in IL-10-/- mice (P < 0.05). Circulating antibody (IL-10-/-, 1.05 +/- 0.16 OD units; IL-10+/+, 0.63 +/- 0.08 OD units) and cutaneous delayed-type hypersensitivity (skin swelling; IL-10-/-, 0.21 +/- 0.03 mm; IL-10+/+, 0.12 +/- 0.02 mm) to the nephritogenic antigen (sheep globulin) were also increased (both P < 0.05). Interferon-gamma production by cultured splenocytes was increased (IL-10-/- 7.9 +/- 2. 5 ng/4 x 106 cells, IL-10+/+ 0.28 +/- 0.09 ng/4 x 106 cells, P < 0. 05), but IL-4 production was unchanged.
Endogenous IL-10 counter-regulates nephritogenic Th1 responses and attenuates crescentic GN.
白细胞介素(IL)-10在调节免疫反应的Th1/Th2优势方面起关键作用。外源性给予IL-10可抑制致肾炎性Th1反应,抑制巨噬细胞功能,并减轻新月体性肾小球肾炎(GN)。为确定内源性IL-10的作用,我们比较了IL-10缺陷(IL-10-/-)和正常(IL-10+/+)C57BL/6小鼠中致肾炎性免疫反应和新月体性GN的发展情况。
通过静脉注射羊抗小鼠肾小球基底膜球蛋白在致敏小鼠中引发GN。21天后评估肾损伤情况。
给予抗肾小球基底膜球蛋白后,正常(IL-10+/+)C57BL/6小鼠发生增殖性GN,偶见新月体形成,肾小球CD4+ T细胞和巨噬细胞积聚,以及纤维蛋白沉积。采用相同的诱导方案,IL-10-/-小鼠发生更严重的GN。新月体形成(IL-10-/-, 占肾小球的23±2%;IL-10+/+, 占5±2%)、肾小球CD4+ T细胞[IL-10-/-, 每个肾小球横截面积(c/gcs)1.0±0.2个细胞;IL-10+/+, 0.3±0.05 c/gcs]、肾小球巨噬细胞(IL-10-/-, 4.8±0.3 c/gcs;IL-10+/+, 1.7±0.2 c/gcs)、纤维蛋白沉积[纤维蛋白评分(范围0至3+);IL-10-/-, 1.10±0.04;IL-10+/+, 0.6±0.07]以及血清肌酐(IL-10-/-, 30±2 μmol/L;IL-10+/+, 23±1 μmol/L)在IL-10-/-小鼠中均显著增加(P<0.05)。对致肾炎性抗原(羊球蛋白)的循环抗体(IL-10-/-, 1.05±0.16 OD单位;IL-10+/+, 0.63±0.08 OD单位)和皮肤迟发型超敏反应(皮肤肿胀;IL-10-/-, 0.21±0.03 mm;IL-10+/+, 0.12±0.02 mm)也增加(均P<0.05)。培养的脾细胞产生的干扰素-γ增加(IL-10-/- 7.9±2.5 ng/4×106细胞,IL-10+/+ 0.28±0.09 ng/4×106细胞,P<0.05),但IL-4产生未改变。
内源性IL-10对致肾炎性Th1反应起反向调节作用,并减轻新月体性GN。